Tissue Factor pathway

Bailliere's Best Practice and Research in Clinical Haematology

Volumn 12, Issue 3, 1999, Pages 361-372

  McVey, John H ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Coagulation; Factor VII; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; CALCIUM; CELL RECEPTOR; FIBRIN; PHOSPHOLIPID; THROMBOPLASTIN;

BLOOD CLOTTING; BLOOD VESSEL INJURY; CELL SURFACE; ENZYME ACTIVE SITE; FIBRIN DEPOSITION; HUMAN; INFLAMMATION; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; STOICHIOMETRY;

EID: 0033510324     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.1999.0030     Document Type: Article

References (58)

1. Nemerson Y. Tissue factor and hemostasis. Blood. 71:1988;1-8.
2. Lawson J H, Kalafatis M, Stram S, Mann K G. A model for the tissue factor pathway to thrombin. I. An empirical study. Journal of Biological Chemistry. 269:1994;23357-23366.
3. Jones K C, Mann K G. A model for the tissue factor pathway to thrombin. II. A mathematical simulation. Journal of Biological Chemistry. 269:1994;23367-23373.
4. Butenas S, Van't Veer C, Mann K G. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. Journal of Biological Chemistry. 272:1997;21527-21533.
5. Cawthern K M, Van't Veer C, Lock J B. Blood coagulation in hemophilia A and hemophilia C. Blood. 91:1998;4581-4592.
6. Morrissey J H, Macik B G, Neuenschwander P F, Comp P C. Quantitation of activated factor-vii levels in plasma using a tissue factor mutant selectively deficient in promoting factor-VII activation. Blood. 81:1993;734-744.
7. Bauer K A. Activation of the factor VII tissue factor pathway. Thrombosis and Haemostasis. 78:1997;108-111.
8. Koster T, Rosendaal F R, Briet E. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood. 85:1995;2756-2761.
9. Allaart C F, Poort S R, Rosendaal F R. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet. 341:1993;134-138.
10. Bertina R M, Koeleman B P, Koster T. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:1994;64-67.
11. Koster T, Rosendaal R F, De Ronde H. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 342:1993;1503-1506.
12. Thaler E, Lechner K. Antithrombin III deficiency and thromboembolism. Clinical Haematology. 10:1981;369-390.
13. Van't Veer C, Mann K G. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. Journal of Biological Chemistry. 272:1997;4367-4377.
14. Drake T A, Morrissey J H, Edgington T S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. American Journal of Pathology. 134:1989;1087-1097.
15. Camerer E, Kolsto A B, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thrombosis Research. 81:1996;1-41.
16. Osterud B. Tissue factor expression by monocytes: regulation and pathophysiological roles. Blood Coagulation and Fibrinolysis. 9:1998;S9-S14.
17. Taubman M B, Fallon J T, Schecter A D. Tissue factor in the pathogenesis of atherosclerosis. Thrombosis and Haemostasis. 78:1997;200-204.
18. Rickles F R, Hair G A, Zeff R A. Tissue factor expression in human leukocytes and tumor cells. Thrombosis and Haemostasis. 74:1995;391-395.
19. Robson S C, Schulte A E, Bach F H. Factors in xenograft rejection. Annals of the New York Academy of Sciences. 875:1999;261-276.
20. Taylor-FB J, Chang A, Ruf W. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circulatory Shock. 33:1991;127-134.
21. Bach R, Rifkin D B. Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proceedings of the National Academy of Sciences of the USA. 87:1990;6995-6999.
22. Wolberg A S, Monroe D M, Roberts H R, Hoffman M R. Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coagulation and Fibrinolysis. 10:1999;201-210.
23. Carmeliet P, Collen D. Molecules in focus - Tissue factor. International Journal of Biochemistry and Cell Biology. 30:1998;661-667.
24. Fisher K L, Gorman C M, Vehar G A. Cloning and expression of human tissue factor cDNA. Thrombosis Research. 48:1987;89-99.
25. Spicer E K, Horton R, Bloem L. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proceedings of the National Academy of Sciences of the USA. 84:1987;5148-5152.
26. Morrissey J H, Fakhrai H, Edgington T S. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell. 50:1987;129-135.
27. Scarpati E M, Wen D, Broze G JJ. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry. 26:1987;5234-5238.
28. Bach R, Konigsberg W H, Nemerson Y. Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine. Biochemistry. 27:1988;4227-4231.
29. Zioncheck T F, Roy S, Vehar G A. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. Journal of Biological Chemistry. 267:1992;3561-3564.
30. Paborsky L R, Tate K M, Harris R J. Purification of recombinant human tissue factor. Biochemistry. 28:1989;8072-8077.
31. Harlos K, Martin D MA, O'Brien D P. Crystal structure of the extracellular region of human tissue factor. Nature. 370:1994;662-666.
32. Muller Y A, Ultsch M H, Kelley R F. Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site. Biochemistry. 33:1994;10864-10870.
33. Paborsky L R, Caras I W, Fisher K L, Gorman C M. Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor. Journal of Biological Chemistry. 266:1991;21911-21916.
34. Hagen F S, Gray C L, O'Hara, P. Characterization of a cDNA coding for human factor-VII. Proceedings of the National Academy of Sciences of the USA. 83:1986;2412-2416.
35. Pike A C, Brzozowski A M, Roberts S M. Structure of human factor VIIa and its implications for the triggering of blood coagulation. Proceedings of the National Academy of Sciences of the USA. 96:1999;8925-8930.
36. Kemball-Cook G, Johnson D JD, Tuddenham E GD, Harlos K. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla). Journal of Structural Biology. 127:1999;213-223.
37. Martin D MA, Boys C WG, Ruf W. Tissue factor: molecular recognition and cofactor function. FASEB Journal. 9:1995;852-859.
38. Dickinson C D, Kelly C R, Ruf W. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proceedings of the National Academy of Sciences of the USA. 93:1996;14379-14384.
39. Banner D W, D'Arcy A, Chène C. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature. 380:1996;41-46.
40. 2 +binding to the first epidermal growth factor module of coagulation factor VIIa is important for cofactor interaction and proteolytic function. Journal of Biological Chemistry. 272:1997;17467-17472.
41. 2 +binding to the first epidermal growth factor-like domain of factor VIIa increases amidolytic activity and tissue factor affinity. Journal of Biological Chemistry. 272:1997;19919-19924.
42. Muranyi A, Finn B E, Gippert G P. Solution structure of the N-terminal EGF-like domain from human factor VII. Biochemistry. 37:1998;10605-10615.
43. Ruf W, Miles D J, Rehemtulla A, Edgington T S. Tissue factor residues 157-167 are required for efficient proteolytic activation of factor X and factor VII. Journal of Biological Chemistry. 267:1992;22206-22210.
44. Ruf W, Miles D J, Rehemtulla A, Edgington T S. Tissue factor residues 157-167 are required for efficient proteolytic activation of factor-X and factor-VII. Journal of Biological Chemistry. 267:1992;22206-22210.
45. Roy S, Hass P E, Bourell J H. Lysine residues 165 and 166 are essential for the cofactor function of tissue factor. Journal of Biological Chemistry. 266:1991;22063-22066.
46. +14-Lys) and its functional consequences in a hereditary factor X deficiency (factor X 'Vorarlberg'). Journal of Biological Chemistry. 265:1990;11982-11989.
47. Rezaie A R, Neuenschwander P F, Morrissey J H, Esmon C T. Analysis of the functions of the first epidermal growth factor-like domain of factor X. Journal of Biological Chemistry. 268:1993;8176-8180.
48. Bode W, Fehlhammer H, Huber R. Crystal structure of bovine trypsinogen at 1·8 Å resolution. I. Data collection, application of Patterson search techniques and preliminary structural interpretation. Journal of Molecular Biology. 106:1976;325-335.
49. Higashi S, Matsumoto N, Iwanaga S. Molecular mechanism of tissue factor-mediated acceleration of factor VIIa activity. Journal of Biological Chemistry. 271:1996;26569-26574.
50. Higashi S, Nishimura H, Aita K, Iwanaga S. Identification of regions of bovine factor VII essential for binding to tissue factor. Journal of Biological Chemistry. 269:1994;18891-18898.
51. Novotny W F, Girard T J, Meletich J P, Broze G JJ. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. Journal of Biological Chemistry. 264:1989;18832-18837.
52. Novotny W F, Girard T J, Miletich J P, Broze G JJ. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood. 72:1988;2020-2025.
53. Sandset P M, Abildgaard U, Larsen M L. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thrombosis Research. 50:1988;803-813.
54. Wun T C, Kretzmer K K, Girard T J. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. Journal of Biological Chemistry. 263:1988;6001-6004.
55. Girard T J, McCourt D, Novotny W F. Endogenous phosphorylation of the lipoprotein-associated coagulation inhibitor at serine-2. Biochemical Journal. 270:1990;621-625.
56. Girard T J, Warren L A, Novotny W F. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature. 338:1989;518-520.
57. Callander N S, Rao L V, Nordfang O. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa. Journal of Biological Chemistry. 267:1992;876-882.
58. Baugh R J, Broze G J Jr, Krishnaswamy S. Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. Journal of Biological Chemistry. 273:1998;4378-4386.